New stock news | Zhejiang Zhongjian Technology (002779.SZ) submitted documents to the Hong Kong Stock Exchange.
According to the disclosure of the Hong Kong Stock Exchange on November 25, Zhejiang Zhongjian Technology Co., Ltd. (002779.SZ) has submitted an application to the Hong Kong Stock Exchange's main board.
According to the disclosure on November 25 by the Hong Kong Stock Exchange, Zhejiang Zhongjian Technology Co., Ltd. (002779.SZ) has submitted an application to the Hong Kong Stock Exchange for listing on the main board, with Ping An Securities (Hong Kong) and Sinolink (Hong Kong) Limited as its joint sponsors. According to the prospectus, the company is a high-tech enterprise mainly engaged in the research and development, design, production, and sales of outdoor power equipment products. Zhejiang Zhongjian Technology has been deeply involved in the outdoor power equipment industry for many years and has grown into one of China's major outdoor power equipment manufacturers through continuous technological innovation and excellent product quality. According to data from Zhushi Consulting, based on the 2024 global outdoor power equipment revenue, Zhejiang Zhongjian Technology ranks among the top ten outdoor power equipment manufacturers in China.
Related Articles

New stock news | XGD INC. (300130.SZ) submits application to Hong Kong Stock Exchange, global cumulative sales of electronic payment devices exceed 50 million units.

Zhongjin: Optimistic about the start of a new round of upswing cycle for lithium batteries, energy storage is expected to become the core "driver".

Chengdu Olymvax Biopharmaceuticals Inc (688319.SH) submitted an application for H-share listing on the Hong Kong Stock Exchange and published the application materials.
New stock news | XGD INC. (300130.SZ) submits application to Hong Kong Stock Exchange, global cumulative sales of electronic payment devices exceed 50 million units.

Zhongjin: Optimistic about the start of a new round of upswing cycle for lithium batteries, energy storage is expected to become the core "driver".

Chengdu Olymvax Biopharmaceuticals Inc (688319.SH) submitted an application for H-share listing on the Hong Kong Stock Exchange and published the application materials.

RECOMMEND

Foreign Brands “Take On Chinese Names”: Starbucks And Burger King Change Hands As Chinese Capital’s Localization Scalpel Rewrites Global Rules
25/11/2025

Riding The Momentum Of Gemini 3, “Google Chain” Challenges “Nvidia Chain,” Reshaping The Ai Trading Landscape
25/11/2025

Silver Economy Accelerates As Personal Pension System Marks Three Years — Structural Changes Emerging
25/11/2025


